(Q33347051)

26 July 2017

title

Cholesterol-modifying strategies for Alzheimer's disease (English)

1 reference

26 July 2017

0 references

Miia Kivipelto

2

0 references

author name string

Alina Solomon

series ordinal

1

1 reference

26 July 2017

publication date

1 May 2009

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

26 July 2017

published in

1 reference

26 July 2017

volume

9

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

695-709

1 reference

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

26 July 2017

cites work

1 reference

Apolipoprotein E polymorphism and Alzheimer's disease.

21 January 2018

1 reference

Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease

21 January 2018

1 reference

Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease

21 January 2018

1 reference

Fatty acids, lipid metabolism and Alzheimer pathology.

21 January 2018

1 reference

Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis

21 January 2018

1 reference

21 January 2018

1 reference

Alzheimer's disease - the ways of prevention

21 January 2018

1 reference

Cholesterol as a risk factor for Alzheimer's disease - epidemiological evidence

21 January 2018

1 reference

Cholesterol and neuropathologic markers of AD: a population-based autopsy study

21 January 2018

1 reference

Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology

21 January 2018

1 reference

Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study.

21 January 2018

1 reference

Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study.

21 January 2018

1 reference

Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study.

21 January 2018

1 reference

Brain cholesterol: long secret life behind a barrier.

21 January 2018

1 reference

Cholesterol homeostasis in neurons and glial cells

21 January 2018

1 reference

Lipid rafts, cholesterol, and the brain

21 January 2018

1 reference

Cholesterol homeostasis and the pathophysiology of Alzheimer's disease

21 January 2018

1 reference

Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain.

21 January 2018

1 reference

Oxysterols, cholesterol homeostasis, and Alzheimer disease

21 January 2018

1 reference

Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease

21 January 2018

1 reference

Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol

21 January 2018

1 reference

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

21 January 2018

1 reference

Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice

21 January 2018

1 reference

Serum lipids and hippocampal volume: the link to Alzheimer's disease?

21 January 2018

1 reference

Serum lipids and hippocampal volume: the link to Alzheimer's disease?

21 January 2018

1 reference

Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels

21 January 2018

1 reference

Increased apolipoprotein B serum concentration in Alzheimer's disease

21 January 2018

1 reference

Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease.

21 January 2018

1 reference

The relation between apolipoprotein A-I and dementia: the Honolulu-Asia aging study

21 January 2018

1 reference

Role of cholesterol in amyloid cascade: cholesterol-dependent modulation of tau phosphorylation and mitochondrial function

21 January 2018

1 reference

Alzheimer's disease: the lipid connection

21 January 2018

1 reference

Brain membrane cholesterol domains, aging and amyloid beta-peptides

21 January 2018

1 reference

Amyloid beta as a regulator of lipid homeostasis

21 January 2018

1 reference

Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production

21 January 2018

1 reference

Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin

21 January 2018

1 reference

The involvement of lipid rafts in Alzheimer's disease

21 January 2018

1 reference

Internalization of beta-amyloid peptide by primary neurons in the absence of apolipoprotein E.

21 January 2018

1 reference

Alzheimer's disease: the cholesterol connection

21 January 2018

1 reference

Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders.

21 January 2018

1 reference

Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease

21 January 2018

1 reference

On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells

21 January 2018

1 reference

Differential expression of cholesterol hydroxylases in Alzheimer's disease

21 January 2018

1 reference

Activity-regulated cytoskeleton-associated protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol in vitro

21 January 2018

1 reference

Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling

21 January 2018

1 reference

Pleiotropic effects of statins and related pharmacological experimental approaches

21 January 2018

1 reference

Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease

21 January 2018

1 reference

Differential effects of lovastatin treatment on brain cholesterol levels in normal and apoE-deficient mice

21 January 2018

1 reference

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

Statin therapy for Alzheimer's disease: will it work?

21 January 2018

1 reference

Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex

21 January 2018

1 reference

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

21 January 2018

1 reference

High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs.

21 January 2018

1 reference

Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin

21 January 2018

1 reference

The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain

21 January 2018

1 reference

Statin effects on cholesterol micro-domains in brain plasma membranes

21 January 2018

1 reference

Impact of HMG-CoA reductase inhibition on brain pathology

21 January 2018

1 reference

Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice

21 January 2018

1 reference

Regulation of the lipidation of beta-secretase by statins

21 January 2018

1 reference

Statins reduce amyloid-beta production through inhibition of protein isoprenylation

21 January 2018

1 reference

Alzheimer's disease: cholesterol, membrane rafts, isoprenoids and statins

21 January 2018

1 reference

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses.

21 January 2018

1 reference

Simvastatin enhances learning and memory independent of amyloid load in mice.

21 January 2018

1 reference

Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease

21 January 2018

1 reference

Statins and the risk of dementia

21 January 2018

1 reference

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

21 January 2018

1 reference

Relation of plasma lipids to Alzheimer disease and vascular dementia

21 January 2018

1 reference

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

21 January 2018

1 reference

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

21 January 2018

1 reference

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

21 January 2018

1 reference

Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials

21 January 2018

1 reference

Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study

21 January 2018

1 reference

Reduced risk of incident AD with elective statin use in a clinical trial cohort

21 January 2018

1 reference

Serum lipoprotein levels, statin use, and cognitive function in older women

21 January 2018

1 reference

Statins and cognitive function in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

Effects of atorvastatin on higher functions

21 January 2018

1 reference

Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease

21 January 2018

1 reference

Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E status.

21 January 2018

1 reference

Association of statin use with cognitive decline in elderly African Americans

21 January 2018

1 reference

Plasma lipid levels in the elderly are not associated with the risk of mild cognitive impairment

21 January 2018

1 reference

Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study

21 January 2018

1 reference

Effects of lovastatin on cognitive function and psychological well-being

21 January 2018

1 reference

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults

21 January 2018

1 reference

Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease

21 January 2018

1 reference

Treatment for the secondary prevention of stroke in older patients: the influence of dementia status

21 January 2018

1 reference

Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.

21 January 2018

1 reference

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial

21 January 2018

1 reference

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

21 January 2018

1 reference

Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial.

21 January 2018

1 reference

Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

21 January 2018

1 reference

The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics

21 January 2018

1 reference

Statins and cognitive function.

21 January 2018

1 reference

Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease

21 January 2018

1 reference

The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration

21 January 2018

1 reference

Effects of cardiovascular medications on rate of functional decline in Alzheimer disease.

21 January 2018

1 reference

Use of statins and risk of hospitalization with dementia: a Danish population-based case-control study

21 January 2018

1 reference

Effects of statins on cognitive function in patients with Alzheimer's disease in galantamine clinical trials

21 January 2018

1 reference

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

Vascular cognitive deterioration and stroke

21 January 2018

1 reference

Rethinking the dementia diagnoses in a population-based study: what is Alzheimer's disease and what is vascular dementia?. A study from the kungsholmen project.

21 January 2018

1 reference

Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study

21 January 2018

1 reference

Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study

21 January 2018

1 reference

Statin Use and the Risk of Incident Dementia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERN.09.25

1 reference

26 July 2017

1 reference